MAM
IRON icon

Martingale Asset Management’s Disc Medicine IRON Stock Holding History

Martingale Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,400
Closed -$710K – 816
2024
Q1 		$710K Buy
11,400
+100
+0.9% +$6.48K 0.01% 544
2023
Q4 		$653K Buy
11,300
+1,401
+14% +$71.7K 0.01% 547
2023
Q3 		$465K Buy
+9,899
New +$495K 0.01% 622

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Martingale Asset Management's IRON Position: Q2 2024 in Review

Martingale Asset Management sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 11,400 shares — an estimated $710K sold.

Martingale Asset Management first reported a position in IRON in Q3 2023 and held it in 3 quarters. The position peaked at $710K in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Martingale Asset Management reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Martingale Asset Management sold 11,400 Disc Medicine shares in Q2 2024, an estimated $710K.
  • Martingale Asset Management first reported a position in Disc Medicine in Q3 2023 and held it in 3 quarters.
  • Martingale Asset Management's Disc Medicine position peaked at $710K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Martingale Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.